|
|
|
Stelazine advertisement, 1964. Mental Hospitals, Vol. 15, No. 3. STELAZINE® brand of TRIFLUOPERAZINE offers dramatic and unusually consistent antipsychotic action One of the most distinctive qualities of Stelazine (trifluoperazine, SK&F) is its marked efficacy in patients with hallucinations, delusions and psychotic thought disturbances. Some patients can be restored to effective contact with reality. Many others achieve a substantial lessening in the frequency and intensity of psychotic episodes, permitting fruitful therapeutic contact during the intervals of lucidity. After more than five years of experience, the pre-eminent role of Stelazine (trifluoperazine, SK&F) in the treatment of such patients is recognized throughout psychiatry. Principal side effects, usually dose-related, may include mild skin reaction, dry mouth, insomnia, fatigue, drowsiness, dizziness and neuromuscular (extrapyramidal) reactions. In hospitalized psychiatric patients, muscular weakness, anorexia, rash, lactation and blurred vision may also be observed. For complete prescribing information, please see PDR or available literature. SMITH KLINE & FRENCH LABORATORIES, PHILADELPHIA |